Craig Thompson

Craig Thompson has over 20 years of experience in the pharmaceutical and biotechnology industries. Craig is currently the Chief Executive Officer at Cerevance. Prior to joining Cerevance, Craig served as the President and CEO of NervGen Pharma Corp.

Craig has also held leadership positions at Neurana Pharmaceuticals, Tetraphase Pharmaceuticals, Anthera Pharmaceuticals, and Trius Therapeutics. While at Trius Therapeutics, Craig co-led the Business Development transaction with Bayer for Asia / Pacific / Emerging Markets Territory. Craig also participated in raising over $115M in the public markets and presented the companies commercial and medical capabilities at Investor Conferences and on NDR’s.

Before joining the biotech world, Craig spent 8 years at Pfizer where they ultimately became the Vice President Marketing, Specialty Care.

Craig holds a B.A. in Biology from Hamilton College.

After completing their undergraduate degree at McMaster University, Craig Thompson went on to earn their MBA from the University of Notre Dame - Mendoza College of Business.

Roland Bürli - VP, Drug Discovery, Naidong Ye - VP & Head of CMC, and Carrie Ann Cook - CBO report to Craig Thompson.